SLN Latest Headlines

Silence Therapeutics Prices $175 Million Upsized Offering to Advance siRNA Therapies

Market Chameleon (Wed, 12-Aug 8:46 AM)

SLN’s Q2 2026 Results: Advancing siRNA Therapies and Trimming Losses Amid R&D Progress

Market Chameleon (Mon, 10-Aug 9:52 AM)

Silence Therapeutics Schedules Conference to Reveal Phase 2 SANRECO Data on Divesiran in Polycythemia Vera

Market Chameleon (Mon, 10-Aug 7:05 AM)